Evommune, Inc. (EVMN) ROA
- 2026-06-30: ROA -31.35%.
- 2026-03-31: ROA -23.57%.
- 2025-12-31: ROA -30.62%.
- 2025-09-30: ROA -72.53%.
Complete source-backed roa history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -31.35% |
| 2026-03-31 | -23.57% |
| 2025-12-31 | -30.62% |
| 2025-09-30 | -72.53% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -30.62% |
| 2024-12-31 | -87.84% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |